Medical News

---

• Diabetic blood pressure target challenged
• Diabetic blood pressure target challenged
• Diabetic blood pressure target challenged
• Spirometry boosts influenza vaccination in COPD
• Early respiratory infections have lasting impact
• Sleep disturbance persists in women with ovarian cancer
• Spirometry boosts influenza vaccination in COPD
• Post-surgery soy offers no prostate cancer advantage2
• Some mRCC patients miss out on molecular era benefits

Diabetic blood pressure target challenged Posted: 14 Jul 2013 05:00 PM PDT A long follow up of a large sample of community-based patients with diabetes suggests that the current guideline blood pressure targets may be too low.

Diabetic blood pressure target challenged Posted: 14 Jul 2013 05:00 PM PDT A long follow up of a large sample of community-based patients with diabetes suggests that the current guideline blood pressure targets may be too low.

Diabetic blood pressure target challenged Posted: 14 Jul 2013 05:00 PM PDT A long follow up of a large sample of community-based patients with diabetes suggests that the current guideline blood pressure targets may be too low.

Spirometry boosts influenza vaccination in COPD Posted: 14 Jul 2013 05:00 PM PDT Increasing the use of spirometry could help increase the rate of influenza vaccination among patients with chronic obstructive pulmonary disease, say researchers.

Early respiratory infections have lasting impact Posted: 14 Jul 2013 05:00 PM PDT Research shows that childhood lower respiratory tract infections are associated with impaired lung function in adulthood, but only when they occur in the first year of life.

Sleep disturbance persists in women with ovarian cancer Posted: 14 Jul 2013 05:00 PM PDT Sleep disturbance appears to be common in women with ovarian cancer and persists for up to 1 year after diagnosis, study findings show.

Spirometry boosts influenza vaccination in COPD Posted: 14 Jul 2013 05:00 PM PDT Increasing the use of spirometry could help increase the rate of influenza vaccination among patients with chronic obstructive pulmonary disease, say researchers.

Post-surgery soy offers no prostate cancer advantage2 Posted: 14 Jul 2013 05:00 PM PDT A US randomized trial of the effects of soy consumption after prostatectomy has ended early after investigators found no benefit in terms of prostate cancer recurrence.

Some mRCC patients miss out on molecular era benefits Posted: 14 Jul 2013 05:00 PM PDT Researchers report that certain subgroups of Japanese patients with metastatic renal cell carcinoma fare no better since the introduction of molecular-targeted therapies than patients treated with cytokine-based immunotherapy alone.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610